Year: 2006
Type: article
Abstract: The remarkable success of the US 1983 Orphan Drug act might be replicated for small-firm patents by adopting its provision of a limited term during which the protection cannot be questioned.
Author: William Kingston
Language: English
Subfield: Management of Technology and Innovation
Domain: Social Sciences
Open Access status: green
OpenAlex ID: W1493579370